Aniruddha Rajurkar succeeds Dr Arun Atrey as CEO, with Dr Atrey staying on as MD and Board Member to guide growth and mentor Rajurkar.
The acquisition will not result in job losses, with Martin & Martin continuing operations at its current facilities to ensure employee stability.
The transaction is expected to close in the coming weeks, subject to customary conditions.